FDA
approval
· 2015-01-29
FDA Approved: EVOTAZ — Original Application (E.R. Squibb & Sons, L.L.C.)
Summary
FDA approved EVOTAZ, a fixed-dose combination of atazanavir and cobicistat for the treatment of HIV-1 infection, with cobicistat acting as a pharmacokinetic boo…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for EVOTAZ (ATAZANAVIR AND COBICISTAT)